stderr : Compounding isn't for mass sales. Often they crush pills and mix with a liquid. The drug settles on bottom of the bottle and you must shake up to use. If you don't do it right, wrong dose. Companies spend big money to get liquid versions approved, ordering pills from China and crushing them up doesn't cut it. Novo should protect its IP

stderr : They need to find funding. Compare to Mesoblast before it tried bla for third time

stderr Buddahs World : Tomatoes, tomahtoes

stderr : They sold fda approved asset to pay debt, I don't know why they are up today. Perhaps it's just OTC nonsense

stderr : supposed to be phase 2/3

stderr : AI always has to be right, so when you ask for something that doesn't exist, it will often make up an answer.  Currently, it is telling me the window company is privately held. It probably learned from its discussion with you

stderr : When APLT?

stderr : Why? I was thinking of buying

stderr Zahid007 OP : Assuming 35mm for next 4 quarters, that's 140mm. Losses were about 100mm last year moderated by fda approval ramp. Does this mean it's right around break even? This might change from trade to investment today